ResMed, Inc. RMD recently introduced its AirCurve 11 series devices ... 11 continue to be more than double that of AirSense ...

Currently, ResMed has a market capitalization of $31.65 billion. Buying $1000 In RMD: If an investor had bought $1000 of RMD stock 10 years ago, it would be worth $4,330.25 today based on a price ...

ResMed (NYSE: RMD, ASX: RMD) launched today its AirCurve 11 series devices, the company’s newest bilevel devices that use two l MatrixCare has been named a market leader by KLAS Research for its ...

Art Walk began with a simple vision of a mural and has transformed into a catalyst leading to a contagious community enthusiasm further fueling Atmore’s sense of pride and the forward-focused ...

ResMed rolled out the AirCurve 11 series, upgrading the AirSense 11 platform with bi-level and improved ventilation therapy choices. It also introduced the AirFit F40 in the U.S., a compact full ...

Hello. And welcome to the Q3 Fiscal Year 2024 ResMed Earnings Conference Call. My name is Kevin, and I’ll be your operator for today’s call. At this time, all participants are in a listen-only ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides the upcoming ex ...

The ResMed Inc. (ASX: RMD) share price is on the move on Friday morning. At the time of writing, the sleep treatment focused medical device company's shares are up 7.5% to $38.41. This means the ...

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Amy Wakeham; Chief IR Officer; ResMed Inc. Brett A. Sandercock; CFO; ResMed Inc. Michael J. Farrell; CEO & Chairman; ResMed Inc. Anthony Charles Petrone; MD & Senior ...